Stocks TelegraphStocks Telegraph
Stock Ideas

FBRX Company Profile and Key Details

NASDAQ : FBRX

Forte Biosciences

$26.52
-0.77-2.82%
At Close 4:00 PM
54.4
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Forte Biosciences, Inc. (FBRX) stock declined over -2.82%, trading at $26.52 on NASDAQ, down from the previous close of $27.29. The stock opened at $28.00, fluctuating between $26.37 and $28.10 in the recent session.

Stock Snapshot

27.29
Prev. Close
368.25M
Market Cap
26.37
Day Low
-5.63
P/E Ratio
-4.71
EPS (TTM)
-0.79
Cash Flow per Share
28
Open
13.89M
Number of Shares
28.1
Day High
82.22%
Free Float in %
0.97
Book Value
109K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
May 06, 202627.4128.3026.3326.52109K
May 05, 202628.7029.1526.9227.29151.61K
May 04, 202627.8130.4127.7628.51208.39K
Apr 30, 202627.8928.2126.5026.66148.95K
Apr 29, 202626.5728.4626.1028.03323.5K
Apr 28, 202626.7927.0526.1026.39237.2K
Apr 27, 202627.5128.8826.0226.80182.59K
Apr 23, 202630.0130.5528.0728.86228.65K
Apr 22, 202633.3333.3329.5729.83227.1K
Apr 21, 202634.5034.8232.7432.84184.66K
Apr 20, 202633.8734.7032.8534.43178.43K
Apr 17, 202632.3833.9530.9533.92445.17K
Apr 16, 202630.9131.5729.7631.43201.78K
Apr 14, 202630.6134.6030.6132.42292.3K
Apr 13, 202634.4235.5529.3930.60523.09K
Apr 10, 202633.8735.4832.4635.09778.6K
Apr 09, 202629.1435.8027.9033.902.74M
Apr 08, 202626.9828.1125.0926.27117.68K
Apr 07, 202626.3327.4925.5326.17188.12K
Apr 06, 202625.8026.7825.5726.44151.91K

Contact Details

Dallas, TX 75247

United States

https://www.fortebiorx.com310 618 6994

About Company

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Company Information

Employees14
Beta3.23
Sales or Revenue$0.00
5Y Sales Change%-1%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Company Overview

Forte Biosciences, Inc. (NASDAQ:FBRX) closed at $26.52 USD, losing -$0.77 (-2.82%) from the previous close of $27.29. The stock is currently mid-range between its 52-week high and low $6.19 and $35.80. With a market capitalization of about $368.25 million, Forte Biosciences, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~3.20). Key stats such as the average daily volume over the past year has been around 275.58 thousand shares, volume is running light vs its 52-week average. Headquartered in Dallas, TX, Forte Biosciences, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Paul A. Wagner, the company employs approximately 14 people and listed since April 13, 2017. Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -2.54%, SMA50 1.05%, SMA200 75.26%). The stock’s 14-day RSI is 49.41 (neutral), while the ATR of 2.8 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.86% below its high and over 497.14% above its low. Average 10-day trading volume of 194.46 thousand shares is below the 3-month average of 267.42 thousand, indicating normal recent market interest.

Valuation Metrics

Forte Biosciences, Inc. trades at a P/E ratio of -56.79, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 64.6 reflecting a rich premium to book value. The P/FCF stands at -7.29, also below market averages. Compared to sector medians, Forte Biosciences, Inc. P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Forte Biosciences, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.52. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Forte Biosciences, Inc. generated EPS of -$4.44 over the past year. Five-year average earnings growth is 24.08%. Wall Street analysts project EPS growth of 29.76% annually over the next five years. The latest quarter delivered EPS of -$1.45. The next quarter is forecast at -$1.18. Next year's EPS is expected at -$8.62. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $75.00 to $61.00. The high target offers 182.81% upside. The low target suggests 130.02% downside. The mean target is $64.60. This offers 143.59% upside. Forte Biosciences, Inc. earnings surprise history is a mixed track record. The quarter that ended March 31, 2026, missed forecasts by 2.11%. The prior quarter beat by -4.45%. Over the last six quarters, Apple has recorded several small beats. These include -32.74% in November 14, 2024.

Shareholding & Insider Activity

Forte Biosciences, Inc. has 12.43 million shares outstanding. The public float is 10.22 million shares, elevated short interest at 1.25% of float. This equals 128.75 thousand shares. The short ratio is 2.4 days. Institutional investors hold 89.92% of the float. Insiders own 4.96%. Oliveira Steven Michael holds 2.87 million shares, Wagner Paul A. has 1.82 million shares and Hasnain Faheem has 241.72 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Frequently Asked Questions

What is the current Forte Biosciences, Inc. (FBRX) stock price?
Forte Biosciences, Inc. (NASDAQ: FBRX) stock price is $26.52 in the last trading session. During the trading session, FBRX stock reached the peak price of $28.10 while $26.37 was the lowest point it dropped to. The percentage change in FBRX stock occurred in the recent session was -2.82% while the dollar amount for the price change in FBRX stock was - $0.77.
FBRX's industry and sector of operation?
The NASDAQ listed FBRX is part of Biotechnology industry that operates in the broader Healthcare sector. Forte Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of FBRX?
Dr. Hubert C. Chen M.D.
Senior Vice President of Clinical Devel.
Mr. Antony A. Riley CPA
Chief Financial Officer
Mr. Christopher Roenfeldt
Chief Operating Officer
Mr. Steven Ruhl
Chief Technical Officer
Dr. Paul A. Wagner Ph.D.
Chief Executive Officer & Chairman
How FBRX did perform over past 52-week?
FBRX's closing price is 332.63% higher than its 52-week low of $6.19 where as its distance from 52-week high of $35.80 is -25.92%.
How many employees does FBRX have?
Number of FBRX employees currently stands at 14.
Link for FBRX official website?
Official Website of FBRX is: https://www.fortebiorx.com
How do I contact FBRX?
FBRX could be contacted at phone 310 618 6994 and can also be accessed through its website. FBRX operates from 3060 Pegasus Park Drive, Dallas, TX 75247, United States.
How many shares of FBRX are traded daily?
FBRX stock volume for the day was 109K shares. The average number of FBRX shares traded daily for last 3 months was 275.58K.
What is the market cap of FBRX currently?
The market value of FBRX currently stands at $368.25M with its latest stock price at $26.52 and 13.89M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph